Heparins/Anticoagulants: Size and Potential
Global market for anticoagulant treatments is est. ~$6 billion, growing at 15% annually
Oral anti-coagulants sales > $600 million
Currently under prescribed for relevant indications
Growth to continue via penetration of surgical and cardiovascular markets
Source: UBS Warburg “Thrombosis,” August 2000; pages 14, 72
Source: “Seminars in Thrombosis and Hemostatis”, Editor-in-Chief: E.F. Mammen, M.D., v.26: 1p. 20.